Showing results (101-110 of 443) with videos related to
Sort By:
Pageof 45
Veterinary and Comparative Oncology|May 10, 2020
Developments and translational relevance for the canine haematopoietic cell transplantation preclinical modelScott S Graves, Rainer StorbExpert Opinion on Biological Therapy|January 16, 2008
Using allogeneic stem cell/T-cell grafts to cure hematologic malignanciesAndrew R Rezvani, Rainer StorbNature Reviews. Cancer|May 7, 2002
History of haematopoietic stem-cell transplantationMarie-Térèse Little, Rainer StorbFrontiers in Oncology|July 8, 2026
Radioimmunotherapy as a targeted strategy of reduced-intensity conditioning for allogeneic transplantation in leukemiaPhuong T Vo, Johnnie J Orozco, Brenda M SandmaierHaematologica|October 12, 2010
Thymic recovery after allogeneic hematopoietic cell transplantation with non-myeloablative conditioning is limited to patients younger than 60 years of ageEmilie Castermans, Muriel Hannon, Jacques Dutrieux, et al.Cancer Research|February 27, 2009
Biodistributions, myelosuppression, and toxicities in mice treated with an anti-CD45 antibody labeled with the alpha-emitting radionuclides bismuth-213 or astatine-211Hirohisa Nakamae, D Scott Wilbur, Donald K Hamlin, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 15, 2009
Delaying DLA-haploidentical hematopoietic cell transplantation after total body irradiationYunchuan Ding, Marcello Rotta, Scott S Graves, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 21, 2010
Outcome of allogeneic hematopoietic cell transplantation from HLA-identical siblings for severe aplastic anemia in patients over 40 years of ageDario Sangiolo, Rainer Storb, H Joachim Deeg, et al.Leukemia|January 25, 2020
Impact of pretransplant measurable residual disease on the outcome of allogeneic hematopoietic cell transplantation in adult monosomal karyotype AMLLinde M Morsink, Megan Othus, Evandro D Bezerra, et al.Transplantation|March 30, 2006
Extending postgrafting cyclosporine decreases the risk of severe graft-versus-host disease after nonmyeloablative hematopoietic cell transplantationLauri Burroughs, Marco Mielcarek, Wendy Leisenring, et al.Pageof 45